Tracking safety and performance of brain aneurysm flow diverters
Part of Brain & nervous system, Heart & circulation clinical trials.
This study collects information from patients in France who are being treated for a brain aneurysm with specific flow diversion devices (p64, p48 MW, or p64 MW). The goal is to confirm that these devices are safe and work well in real-world use, which can help doctors make better treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a brain aneurysm (including a ruptured one in certain situations, or multiple aneurysms) that is being treated or planned to be treated with a p64, p48 MW, or p64 MW device.
- You (or your legal representative) agree to allow your medical data to be collected and processed for this registry.
- You are not participating in another research study that changes your standard treatment.
- You are able to attend the usual follow-up visits at the site.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special metal mesh tube, called a flow diverter, to treat unruptured brain aneurysms. The goal is to see how safe and effective it is for preventing strokes.
This trial collects information about the use of a specific stroke treatment device in real-world medical practice. It helps researchers see how well this device works for a wide range of patients, not just those in strict study conditions.
This study is a registry that collects information from patients who have had a brain aneurysm treated with a special type of device called a flow diverter or flow disruptor. By joining, you help doctors learn more about how well these treatments work over time and which patients benefit most.
This trial tests a special device (p48/64 MW HPC) to treat certain brain aneurysms that are wide-necked or have a shape that makes them hard to treat. It might help people with aneurysms that haven't ruptured or that have been treated before and are now coming back.
This trial tests a new device called the Surpass Elite with GUARDian Flow Diverter to treat a single, unruptured brain aneurysm. If you have a wide-neck aneurysm on the internal carotid artery or its branches, this study may help determine if the device is safe and effective for you.
This trial tests a small metal mesh tube (called a flow diverter) that is placed inside the brain artery to treat a type of aneurysm that is not a simple round pouch. The goal is to see if it is safe and helps prevent the aneurysm from growing or bursting.
Hear when a new Intracranial Aneurysms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.